ABSI
Price
$11.35
Change
+$0.46 (+4.22%)
Updated
Jun 29, 04:59 PM (EDT)
Capitalization
1.92B
50 days until earnings call
Intraday BUY SELL Signals
BEAM
Price
$34.97
Change
+$0.16 (+0.46%)
Updated
Jun 29, 04:59 PM (EDT)
Capitalization
3.6B
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs BEAM

ABSI vs BEAM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABSI vs. BEAM commentary
Jun 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Buy and BEAM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2026
Stock price -- (ABSI: $10.89 vs. BEAM: $34.81)
Brand notoriety: ABSI and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 200% vs. BEAM: 213%
Market capitalization -- ABSI: $1.92B vs. BEAM: $3.6B
ABSI [@Biotechnology] is valued at $1.92B. BEAM’s [@Biotechnology] market capitalization is $3.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $126.81B to $0. The average market capitalization across the [@Biotechnology] industry is $2.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +29.64% price change this week, while BEAM (@Biotechnology) price change was -2.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.89%. For the same industry, the average monthly price growth was -0.41%, and the average quarterly price growth was +1915.34%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 18, 2026.

BEAM is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+1.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($3.6B) has a higher market cap than ABSI($1.92B). ABSI YTD gains are higher at: 212.034 vs. BEAM (25.577). ABSI has higher annual earnings (EBITDA): -106.8M vs. BEAM (-349.25M). BEAM has more cash in the bank: 1.21B vs. ABSI (126M). ABSI has less debt than BEAM: ABSI (4.42M) vs BEAM (251M). BEAM has higher revenues than ABSI: BEAM (164M) vs ABSI (1.84M).
ABSIBEAMABSI / BEAM
Capitalization1.92B3.6B53%
EBITDA-106.8M-349.25M31%
Gain YTD212.03425.577829%
P/E RatioN/AN/A-
Revenue1.84M164M1%
Total Cash126M1.21B10%
Total Debt4.42M251M2%
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIBEAM
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 27 days ago
89%
Bearish Trend 18 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
BEAM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PRN249.37N/A
N/A
Invesco Dorsey Wright IndustrialsMomtETF
GEME42.68N/A
N/A
Pacific NoS Global EM Equity Active ETF
CCRP19.65N/A
N/A
Columbia Corporate Bond ETF
BKSE133.77-0.28
-0.21%
BNY Mellon US Small Cap Core Equity ETF
GNR67.08-0.19
-0.28%
State Street® SPDR® S&P® Glb Ntrl Rs ETF

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
N/A
RXRX - ABSI
57%
Loosely correlated
N/A
ABCL - ABSI
54%
Loosely correlated
N/A
CRSP - ABSI
54%
Loosely correlated
N/A
CRBU - ABSI
48%
Loosely correlated
N/A
BEAM - ABSI
47%
Loosely correlated
N/A
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
N/A
CRSP - BEAM
72%
Closely correlated
N/A
EDIT - BEAM
63%
Loosely correlated
N/A
PRME - BEAM
63%
Loosely correlated
N/A
NTLA - BEAM
60%
Loosely correlated
N/A
AXON - BEAM
57%
Loosely correlated
N/A
More